Endoscopic negative-pressure therapy for anastomotic leaks after upper gastrointestinal surgery: systematic review and meta-analysis
Authors:
- Santiago Alonso GómezSGSantiago Alonso Gómez
- María Donat GarridoMGMaría Donat Garrido
- Carlos Miliani MolinaCMCarlos Miliani Molina
- Sagrario Martínez CortijoSCSagrario Martínez Cortijo
- Elías Rodríguez CuellarECElías Rodríguez Cuellar
- Eduardo Ferrero HerreroEHEduardo Ferrero Herrero
- Javier Dagnesses-FonsecaJDJavier Dagnesses-Fonseca
Open Access
- 20 April 2026
- journal article
- review article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (5) , 3666-3682
Abstract
Background: UGI anastomotic leaks are severe postoperative complications associated with substantial morbidity, mortality, and prolonged hospitalization. EVT is a minimally invasive alternative to conventional approaches, but evidence has not been comprehensively synthesized. Methods: This systematic review and meta-analysis was reported in accordance with the PRISMA 2020 statement. Observational studies (January 2015–January 2025) identified in PubMed, Embase, Cochrane, and LILACS. Adults with UGI anastomotic leaks treated with EVT were eligible. Random-effects models pooled proportions using the Freeman–Tukey double-arcsine transformation; sensitivity analyses used a logit transformation. Pre-specified subgroup analyses stratified by surgical indication (oncologic, bariatric, mixed), leak location (intrathoracic vs intra-abdominal), and risk of bias. Risk of bias was appraised using the Joanna Briggs Institute (JBI) critical appraisal checklist for case series and certainty of evidence with GRADE. Results: Thirty-one studies ( n = 767) were included. The pooled clinical success was 87% (95% CI, 82–91%) and remained high in sensitivity analyses (84–89%). No material differences were observed across oncologic, bariatric, or mixed series. Intrathoracic leaks showed lower success than intra-abdominal leaks (79 vs 95%). Thirty-day mortality was 7%, primarily in complex clinical contexts. Heterogeneity was substantial, and small-study effects were suspected. Overall certainty of evidence was rated low owing to observational design and risk of bias. Conclusions: Across observational studies, EVT achieved high clinical success for UGI anastomotic leaks with low short-term mortality. Prospective cohorts and randomized trials are needed to refine indications, identify predictors of response, and assess cost-effectiveness.Keywords
Funding Information
- Universidad Rey Juan Carlos
This publication has 50 references indexed in Scilit:
- Closing the gap: endoscopic treatment of esophageal anastomotic leakage—a retrospective cohort studySurgical Endoscopy, 2025
- Effects of endoluminal vacuum sponge therapy on the perfusion of gastric conduit in a porcine model for esophagectomySurgical Endoscopy, 2024
- Comparison of long-term quality of life outcomes between endoscopic vacuum therapy and other treatments for upper gastrointestinal leaksSurgical Endoscopy, 2023
- Endoscopic vacuum therapy significantly improves clinical outcomes of anastomotic leakages after 2-stage, 3-stage, and transhiatal esophagectomiesLangenbeck's Archives of Surgery, 2023
- Endoscopic vacuum therapy in salvage and standalone treatment of gastric leaks after bariatric surgeryLangenbeck's Archives of Surgery, 2021
- Clinical and economic burden of colorectal and bariatric anastomotic leaksSurgical Endoscopy, 2019
- Endoscopic Vacuum Therapy in the Management of Postoperative Leakage After EsophagectomyWorld Journal of Surgery, 2019
- Successful closure of defects in the upper gastrointestinal tract by endoscopic vacuum therapy (EVT): a prospective cohort studySurgical Endoscopy, 2016
- The use of endoluminal vacuum (E-Vac) therapy in the management of upper gastrointestinal leaks and perforationsSurgical Endoscopy, 2015
- Comparison of Endoscopic Vacuum Therapy Versus Stent for Anastomotic Leak After EsophagectomyJournal of Gastrointestinal Surgery, 2015